What Is It, and Why Does It Matter? Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of ...
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Upcoming US approval decisions in the third quarter of 2026 include centanafadine for attention deficit hyperactivity disorder (ADHD), 177 Lu-edotreotide for gastroenteropancreatic neuroendocrine ...
The global rise in anticoagulant use has increased the number of major bleeding events that warrant timely and effective pharmacologic reversal. Reversal strategies should be informed by the ...
Most urinary tract infections (UTIs) are simple and easy to treat. With proper treatment, they rarely lead to serious problems. But sometimes, a UTI can lead to bigger problems. If a UTI gets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results